Reynolds Tobacco Company Wins U.S. Supreme Court Support to Challenge FDA Ruling Locally

Jun.23
Reynolds Tobacco Company Wins U.S. Supreme Court Support to Challenge FDA Ruling Locally
On June 20, the U.S. Supreme Court ruled 7-2 in favor of e-cigarette companies, making it easier for them to sue over FDA decisions blocking product market entry. The case, filed by RJ Reynolds, challenges FDA’s denial of the Vuse Alto e-cigarette. The ruling could shift the balance between the industry and regulators.

Key Points:

 

·Court ruling: In a 7-2 decision, the Supreme Court supports e-cigarette companies, loosening litigation restrictions and allowing more businesses to challenge FDA bans. 

 

·Case background: Reynolds e-cigarette company (RJ Reynolds) filed a lawsuit against the FDA for refusing to authorize its Vuse Alto e-cigarette. 

 

·The company partnered with retailers in Texas, a conservative majority state, to file the lawsuit in the Fifth Circuit Court of Appeals. 

 

·Legal impact: Retailers and distributors affected by FDA decisions can now file lawsuits in local courts, not just manufacturers. 

 

·This may increase e-cigarette companies' chances of choosing favorable courts. 

 

·Judicial division: Majority opinion (Justice Barrett): Believes the law allows affected businesses (like retailers) to file lawsuits. 

 

·Dissenting opinion (Justices Jackson and Sotomayor): Warns that the ruling could undermine regulatory consistency and promote evasion behavior. 

 

·Industry and regulatory conflict: FDA has recently strengthened control over flavored e-cigarettes, but the industry continues to push back through legal means. 

 

·This ruling may weaken FDA's regulatory efforts and impact the future landscape of the e-cigarette market.

 

·The ruling marks a key victory for the e-cigarette industry in its fight against federal regulations, potentially leading to more similar lawsuits and further affecting e-cigarette policies in the US.

 


 

According to a report from the Associated Press on June 20th, the Supreme Court of the United States voted 7-2 in favor of Reynolds Vapor Co., a subsidiary of Reynolds Tobacco, allowing them to challenge the FDA's decision to refuse their e-cigarette marketing application in the Fifth Circuit Court of Appeals.

 

At the time of this ruling, major e-cigarette companies are opposing the federal government's years-long crackdown on e-cigarettes. It is expected that the ruling will give e-cigarette companies more autonomy to decide which judges will preside over lawsuits against e-cigarette entities.

 

In a ruling in April, judges reversed their stance on e-cigarettes, supporting the FDA's decision to maintain a comprehensive ban on most flavored e-cigarettes following a surge in youth vaping.

 

The current case is brought by the Reynolds e-cigarette company, which had already sold a range of popular berry and mint-flavored e-cigarette products before the FDA began regulating the market in accordance with the Tobacco Control Act in 2016.

 

The FDA has rejected approval of the company's Vuse Alto product. Supreme Court Justice Amy Coney Barrett wrote in the majority opinion that this decision "rings the death knell for a significant portion of the e-cigarette market.

 

The company is headquartered in North Carolina, where it is typically only able to challenge the FDA in local courts or in the FDA's headquarters in Washington D.C. However, the company has teamed up with a Texas-based business that sells its products to file a lawsuit locally. The conservative U.S. Fifth Circuit Court of Appeals has allowed the lawsuit to proceed, ruling that any business that suffers harm to its operations due to an FDA decision can file a lawsuit.

 

The FDA has filed an appeal to the Supreme Court, alleging that the e-cigarette company Reynolds is attempting to find a favorable court for its arguments.

 

However, judges found that the law does allow other businesses, such as e-cigarette retailers, affected by FDA decisions to file lawsuits in their state.

 

Supreme Court Justices Ketanji Brown Jackson and Sonia Sotomayor, who hold differing opinions, both agree that they will stand by the institution.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

COP11 to Convene in Geneva in November; South Korea May Leverage Global Consensus to Advance Tobacco-Control Reforms
COP11 to Convene in Geneva in November; South Korea May Leverage Global Consensus to Advance Tobacco-Control Reforms
The 11th Conference of the Parties (COP11) to the WHO Framework Convention on Tobacco Control (FCTC) will be held in Geneva, Switzerland, from November 7 to 22, 2025. The meeting is expected to focus on the disclosure of tobacco constituents, environmental impacts, and industry responsibility. South Korea plans to implement the Tobacco Harmfulness Management Act in November and is preparing to send a delegation to COP11 to help align domestic regulations with international standards.
Sep.05 by 2FIRSTS.ai
Comparing the UK's Approved E-cigarette Lists (June-August): E-liquids and pods remain the mainstays, while open-system devices saw an accelerated release of new products in August
Comparing the UK's Approved E-cigarette Lists (June-August): E-liquids and pods remain the mainstays, while open-system devices saw an accelerated release of new products in August
Based on the latest data from the MHRA, e-cigarette registrations in the UK showed a "peak in July, drop in August" trend. E-liquids and pods consistently made up about 90% of the total. While pre-filled pod systems were the most common, open-system device registrations notably increased in August.
Sep.04 by 2FIRSTS.ai
Malaysian Police Dismantle Drug Syndicate, Seize About USD 352,000 in MDMA-Laced Vape Oil
Malaysian Police Dismantle Drug Syndicate, Seize About USD 352,000 in MDMA-Laced Vape Oil
Malaysian police have busted a criminal syndicate distributing the new-type drug MDMA and seized e-cigarette vape oil and related items worth approximately RM1.48 million (about USD 352,000). Nine suspects were arrested, including a Thai woman. The case is being investigated under Section 39B of the Dangerous Drugs Act.
Aug.29 by 2FIRSTS.ai
Singapore to Classify Etomidate as Class C Drug from September; Importers and Sellers Face Up to 20 Years in Prison
Singapore to Classify Etomidate as Class C Drug from September; Importers and Sellers Face Up to 20 Years in Prison
Singapore will classify the anesthetic etomidate as a Class C drug from September 1, with traffickers and users facing prosecution and a minimum one-year jail term. The move comes amid growing concerns over the health risks posed by etomidate-laced e-cigarettes, which have become increasingly popular. The government has stepped up enforcement efforts, seizing over 850 e-cigarettes in recent operations.
Aug.25 by 2FIRSTS.ai
Communication Gaps, Illicit Trade, and Product Design Flagged in PMI’s Sustainability Materiality Report 2025
Communication Gaps, Illicit Trade, and Product Design Flagged in PMI’s Sustainability Materiality Report 2025
PMI identifies communication barriers as a core risk to advancing tobacco harm reduction, highlighting how public misunderstanding and regulatory constraints are undermining switching efficiency. Illicit trade, disposable product design, and forced labor in the electronics supply chain are also flagged as high-priority concerns. The report further unveils an independent assessment of its health subsidiary Aspeya, focusing on consumer health, climate impact, and global access—signaling ESG alignm
Sep.15
US FDA Rejects Imperial Tobacco’s blu 2.4% E-Cigarette Application, Citing Failure to Prove Health Benefits Outweigh Risks
US FDA Rejects Imperial Tobacco’s blu 2.4% E-Cigarette Application, Citing Failure to Prove Health Benefits Outweigh Risks
The US Food and Drug Administration (FDA) has issued a Marketing Denial Order (MDO) for Imperial Tobacco’s blu® Disposable Classic Tobacco 2.4% e-cigarette, prohibiting its sale and distribution in the United States. FDA’s review found that the company’s Premarket Tobacco Product Application (PMTA) did not provide sufficient evidence to demonstrate that the product could help smokers fully switch to e-cigarettes or significantly reduce cigarette consumption. Instead, existing evidence suggested
Aug.20 by 2FIRSTS.ai